IN2012DN04085A - - Google Patents

Download PDF

Info

Publication number
IN2012DN04085A
IN2012DN04085A IN4085DEN2012A IN2012DN04085A IN 2012DN04085 A IN2012DN04085 A IN 2012DN04085A IN 4085DEN2012 A IN4085DEN2012 A IN 4085DEN2012A IN 2012DN04085 A IN2012DN04085 A IN 2012DN04085A
Authority
IN
India
Prior art keywords
minutes
relates
enhancing muscle
repeated sprints
protein
Prior art date
Application number
Inventor
Daniel Ryan Moore
Eric Zaltas
John Alan Hawley
Louise Mary Burke
Trent Stellingwerff
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN04085A publication Critical patent/IN2012DN04085A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a method of enhancing muscle protein synthesis following physical exertion comprising administering to a human a composition comprising protein or essential amino acids and carbohydrates 30 minutes or less prior to, during, or within 30 minutes of running repeated sprints. Further, the invention relates to a program for enhancing muscle adaptation resulting from repeated sprints training.
IN4085DEN2012 2009-11-29 2010-11-29 IN2012DN04085A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09177423.2A EP2327316B1 (en) 2009-11-29 2009-11-29 Method of enhancing muscle protein synthesis
PCT/EP2010/068439 WO2011064373A1 (en) 2009-11-29 2010-11-29 Method of enhancing muscle protein synthesis

Publications (1)

Publication Number Publication Date
IN2012DN04085A true IN2012DN04085A (en) 2015-08-07

Family

ID=42135915

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4085DEN2012 IN2012DN04085A (en) 2009-11-29 2010-11-29

Country Status (13)

Country Link
US (1) US20130203645A1 (en)
EP (1) EP2327316B1 (en)
JP (1) JP5810429B2 (en)
CN (1) CN102665445B (en)
AU (1) AU2010323089B2 (en)
BR (1) BR112012012811A2 (en)
CA (1) CA2781764A1 (en)
IN (1) IN2012DN04085A (en)
MX (1) MX2012005646A (en)
NZ (1) NZ600094A (en)
PH (1) PH12012500875A1 (en)
RU (1) RU2503269C1 (en)
WO (1) WO2011064373A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013188422A1 (en) * 2012-06-11 2013-12-19 Nu Science Laboratories, Inc. Nutritional products and methods of improving exercise performance
US10016472B2 (en) 2012-06-11 2018-07-10 William J. Kraemer Methods of mitigating the negative effects of resistance exercise
CN104936466A (en) * 2012-11-20 2015-09-23 普罗努塔利亚公司 Engineered secreted proteins and methods
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
NZ711956A (en) 2013-03-08 2018-06-29 Axiom Foods Inc Rice protein supplements
JP2016516419A (en) * 2013-03-26 2016-06-09 プレミア・ニュートリション・コーポレイション Methods for enhancing muscle protein synthesis following concurrent training
US10271570B2 (en) 2013-08-15 2019-04-30 Nu Science Laboratories, Inc. Compositions for and methods of diet supplementation
WO2015040533A1 (en) * 2013-09-19 2015-03-26 Premier Nutrition Corporation Methods for enhancing muscle protein synthesis during energy deficit
PL238958B1 (en) * 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Amino acid composition based on protein to be used before physical effort
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
EP3634155A4 (en) 2017-05-12 2021-02-17 Axiom Foods Inc. Rice products and systems and methods for making thereof
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
JP2021527670A (en) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100481379B1 (en) * 1996-05-23 2005-05-16 오쓰까 세이야꾸 가부시키가이샤 Food composition for lowering body fat content and improving body composition and method therefor
US6013290A (en) * 1997-11-17 2000-01-11 Weinstein; Robert E. Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
EP1112693B1 (en) * 1999-12-30 2006-03-22 Kerry Group Services Ltd Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
AU2002243267A1 (en) * 2000-10-27 2002-06-24 Mannatech, Inc. Dietary supplement compositions
US7740893B2 (en) * 2001-04-02 2010-06-22 Mott's Llp Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US20030064134A1 (en) * 2001-10-03 2003-04-03 Eastman Outdoors Kit, system and method for preparing home-made nutritional food items
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
JP2005070853A (en) * 2003-08-26 2005-03-17 Md 21:Kk Method for creating menu of diet program, and system of the method
US7205018B2 (en) * 2004-10-07 2007-04-17 Next Proteins, Inc. Carbonated protein drink and method of making
US20070015686A1 (en) * 2005-07-07 2007-01-18 Heuer Marvin A Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells
EP1973426A2 (en) * 2005-11-03 2008-10-01 Southwest Immunology Inc. Compositions for preventing and reducing delayed onset muscle soreness
US20070243290A1 (en) * 2006-04-18 2007-10-18 Melody Thompson Method of tailoring infant formulas to individual nutritional needs prior to use
US20070270355A1 (en) * 2006-05-11 2007-11-22 Garcia Ramon D Sport drink containing amino acids and carbohydrates
RU2306720C1 (en) * 2006-07-06 2007-09-27 Энвер Саидович Токаев "sportamine" product for sportsman's feeding
US20090169684A1 (en) * 2007-12-29 2009-07-02 Cresta Andrea K Fitness and exercise enhancing tablet containing protein isolate
EP2098126A1 (en) * 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate Bar

Also Published As

Publication number Publication date
AU2010323089A1 (en) 2012-05-31
MX2012005646A (en) 2012-06-13
JP5810429B2 (en) 2015-11-11
PH12012500875A1 (en) 2013-01-07
WO2011064373A1 (en) 2011-06-03
HK1175664A1 (en) 2013-07-12
AU2010323089B2 (en) 2014-07-24
JP2013511970A (en) 2013-04-11
EP2327316A1 (en) 2011-06-01
EP2327316B1 (en) 2016-11-16
NZ600094A (en) 2014-10-31
CA2781764A1 (en) 2011-06-03
CN102665445A (en) 2012-09-12
RU2503269C1 (en) 2014-01-10
CN102665445B (en) 2015-03-25
US20130203645A1 (en) 2013-08-08
BR112012012811A2 (en) 2015-09-15

Similar Documents

Publication Publication Date Title
IN2012DN04085A (en)
UA90048C2 (en) Conditioned blood composition and method for its production
MX2010008726A (en) Compositions and methods for influencing recovery from strenuous physical activity.
MX2015013749A (en) Methods for enhancing muscle protein synthesis following concurrent training.
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
TW201129377A (en) Binding proteins that bind to human FGFR1c, human β-Klotho and both human FGFR1c and human β-Klotho
MY151018A (en) Use of nutritional compositions for preventing disorders
MY163119A (en) Use of tenecteplase for treating acute ischemic stroke
MX2009012650A (en) Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders.
NZ724593A (en) Anti-cd70 antibody drug conjugates
MX2010004074A (en) Combination 059.
MX2010003884A (en) ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15.
WO2010130830A3 (en) Anti-sclerostin vhh and their use for treating bone diseases
WO2009032888A3 (en) Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract
EP1670450A4 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
WO2010071826A3 (en) Methods for treating osteoclast-related disease, compounds and compositions thereof
BR112014007675A2 (en) degenerative joint disease treatment
MX353301B (en) Tripeptide compositions and methods for treatment of diabetes.
WO2010019212A3 (en) Methods for enhancing energy metabolism
WO2008112840A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2010000851A3 (en) Methods for modulating angiogenesis via dystrophin dp71
MX2010001381A (en) Genes and proteins of brachyspira hyodysenteriae and uses thereof.
MX2010010177A (en) Improved beta thymosin fragments.
AU2017221784B2 (en) Novel compositions and methods for the treatment of immune related diseases
WO2007107323A8 (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy